2022-10-04 |
2022-09-30 |
V
Vente
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
33
-0.2%
230,49
7 606
USD
|
33
-0.2%
|
230,49
|
7 606
USD
|
|
2022-10-04 |
2022-09-30 |
V
Vente
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
5 189
-26.4%
229,77
1 192 277
USD
|
5 189
-26.4%
|
229,77
|
1 192 277
USD
|
|
2022-10-04 |
2022-09-30 |
V
Vente
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
2 819
-12.5%
228,74
644 818
USD
|
2 819
-12.5%
|
228,74
|
644 818
USD
|
|
2022-10-04 |
2022-09-30 |
V
Vente
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
2 459
-9.8%
227,05
558 316
USD
|
2 459
-9.8%
|
227,05
|
558 316
USD
|
|
2022-09-12 |
2022-09-09 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
5 000
-25.0%
243,46
1 217 300
USD
|
5 000
-25.0%
|
243,46
|
1 217 300
USD
|
|
2022-08-16 |
2022-08-15 |
VP
Vente planifiée
|
OLSON LAURIE J
Administrateur non-exécutif
|
1 000
-100.0%
267,59
267 590
USD
|
1 000
-100.0%
|
267,59
|
267 590
USD
|
|
2022-08-11 |
2022-08-09 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
12 264
-45.0%
228,05
2 796 805
USD
|
12 264
-45.0%
|
228,05
|
2 796 805
USD
|
|
2022-08-11 |
2022-08-09 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
7 033
-31.9%
228,13
1 604 438
USD
|
7 033
-31.9%
|
228,13
|
1 604 438
USD
|
|
2022-08-11 |
2022-08-09 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
5 703
-27.5%
228,10
1 300 854
USD
|
5 703
-27.5%
|
228,10
|
1 300 854
USD
|
|
2022-08-11 |
2022-08-09 |
VP
Vente planifiée
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
16 500
-39.8%
227,83
3 759 195
USD
|
16 500
-39.8%
|
227,83
|
3 759 195
USD
|
|
2022-07-11 |
2022-07-11 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
15 000
-50.0%
133,29
1 999 350
USD
|
15 000
-50.0%
|
133,29
|
1 999 350
USD
|
|
2022-07-01 |
2022-06-30 |
A
Achat
|
HEALY JAMES
Administrateur non-exécutif
|
24 161
+1.2%
123,39
2 981 226
USD
|
24 161
+1.2%
|
123,39
|
2 981 226
USD
|
|
2022-07-01 |
2022-06-30 |
A
Achat
|
HEALY JAMES
Administrateur non-exécutif
|
48 062
+2.4%
122,27
5 876 541
USD
|
48 062
+2.4%
|
122,27
|
5 876 541
USD
|
|
2022-07-01 |
2022-06-29 |
A
Achat
|
HEALY JAMES
Administrateur non-exécutif
|
9 129
+0.5%
125,00
1 141 125
USD
|
9 129
+0.5%
|
125,00
|
1 141 125
USD
|
|
2022-07-01 |
2022-06-29 |
A
Achat
|
HEALY JAMES
Administrateur non-exécutif
|
6 832
+0.3%
124,73
852 155
USD
|
6 832
+0.3%
|
124,73
|
852 155
USD
|
|
2022-07-01 |
2022-06-29 |
A
Achat
|
HEALY JAMES
Administrateur non-exécutif
|
4 039
+0.2%
122,95
496 595
USD
|
4 039
+0.2%
|
122,95
|
496 595
USD
|
|
2022-07-01 |
2022-06-29 |
A
Achat
|
HEALY JAMES
Administrateur non-exécutif
|
27 777
+1.4%
121,99
3 388 516
USD
|
27 777
+1.4%
|
121,99
|
3 388 516
USD
|
|
2022-06-09 |
2022-06-09 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
5 000
-25.0%
110,90
554 500
USD
|
5 000
-25.0%
|
110,90
|
554 500
USD
|
|
2022-05-31 |
2022-05-27 |
VP
Vente planifiée
|
OLSON LAURIE J
Administrateur non-exécutif
|
1 000
-100.0%
110,00
110 000
USD
|
1 000
-100.0%
|
110,00
|
110 000
USD
|
|
2022-05-09 |
2022-05-09 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
5 000
-25.0%
104,10
520 500
USD
|
5 000
-25.0%
|
104,10
|
520 500
USD
|
|
2022-04-21 |
2022-04-21 |
VP
Vente planifiée
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
40
-0.2%
134,46
5 378
USD
|
40
-0.2%
|
134,46
|
5 378
USD
|
|
2022-04-21 |
2022-04-20 |
VP
Vente planifiée
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
704
-2.7%
133,20
93 773
USD
|
704
-2.7%
|
133,20
|
93 773
USD
|
|
2022-04-21 |
2022-04-19 |
VP
Vente planifiée
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
3 500
-12.3%
130,81
457 835
USD
|
3 500
-12.3%
|
130,81
|
457 835
USD
|
|
2022-04-14 |
2022-04-01 |
A
Achat
|
HEALY JAMES
Administrateur non-exécutif
|
47
+7.4%
129,38
6 081
USD
|
47
+7.4%
|
129,38
|
6 081
USD
|
|
2022-04-04 |
2022-04-01 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
7 728
-34.0%
128,45
992 662
USD
|
7 728
-34.0%
|
128,45
|
992 662
USD
|
|
2022-03-02 |
2022-03-01 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
7 728
-38.2%
107,38
829 833
USD
|
7 728
-38.2%
|
107,38
|
829 833
USD
|
|
2022-02-17 |
2022-02-15 |
VP
Vente planifiée
|
OLSON LAURIE J
Administrateur non-exécutif
|
1 000
-100.0%
110,00
110 000
USD
|
1 000
-100.0%
|
110,00
|
110 000
USD
|
|
2022-02-17 |
2022-02-15 |
VP
Vente planifiée
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
1 500
-5.7%
111,14
166 710
USD
|
1 500
-5.7%
|
111,14
|
166 710
USD
|
|
2022-02-02 |
2022-02-01 |
VP
Vente planifiée
|
Pande Atul
Administrateur non-exécutif
|
2 500
-100.0%
110,80
277 000
USD
|
2 500
-100.0%
|
110,80
|
277 000
USD
|
|
2022-02-02 |
2022-02-01 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
7 728
-43.6%
110,05
850 466
USD
|
7 728
-43.6%
|
110,05
|
850 466
USD
|
|
2022-01-03 |
2022-01-03 |
VP
Vente planifiée
|
Pande Atul
Administrateur non-exécutif
|
2 500
-100.0%
130,44
326 100
USD
|
2 500
-100.0%
|
130,44
|
326 100
USD
|
|
2022-01-03 |
2022-01-03 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
7 728
-25.6%
130,79
1 010 745
USD
|
7 728
-25.6%
|
130,79
|
1 010 745
USD
|
|
2021-12-02 |
2021-12-01 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
7 728
-27.9%
127,57
985 861
USD
|
7 728
-27.9%
|
127,57
|
985 861
USD
|
|
2021-12-02 |
2021-12-01 |
VP
Vente planifiée
|
Pande Atul
Administrateur non-exécutif
|
2 500
-100.0%
127,73
319 325
USD
|
2 500
-100.0%
|
127,73
|
319 325
USD
|
|
2021-11-15 |
2021-11-15 |
VP
Vente planifiée
|
OLSON LAURIE J
Administrateur non-exécutif
|
1 000
-100.0%
138,24
138 240
USD
|
1 000
-100.0%
|
138,24
|
138 240
USD
|
|
2021-11-10 |
2021-11-08 |
VP
Vente planifiée
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
13 500
-42.9%
152,32
2 056 320
USD
|
13 500
-42.9%
|
152,32
|
2 056 320
USD
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Pande Atul
Administrateur non-exécutif
|
2 500
-100.0%
136,67
341 675
USD
|
2 500
-100.0%
|
136,67
|
341 675
USD
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
300
-0.6%
144,54
43 362
USD
|
300
-0.6%
|
144,54
|
43 362
USD
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
740
-1.4%
143,78
106 397
USD
|
740
-1.4%
|
143,78
|
106 397
USD
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
787
-1.5%
142,14
111 864
USD
|
787
-1.5%
|
142,14
|
111 864
USD
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
400
-0.7%
140,74
56 296
USD
|
400
-0.7%
|
140,74
|
56 296
USD
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
500
-0.9%
139,87
69 935
USD
|
500
-0.9%
|
139,87
|
69 935
USD
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
100
-0.2%
136,67
13 667
USD
|
100
-0.2%
|
136,67
|
13 667
USD
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
7 625
-30.3%
136,67
1 042 109
USD
|
7 625
-30.3%
|
136,67
|
1 042 109
USD
|
|
2021-11-03 |
2021-11-01 |
VP
Vente planifiée
|
Brannan Stephen K.
Chief Medical Officer
Dirigeant
|
103
-0.6%
136,67
14 077
USD
|
103
-0.6%
|
136,67
|
14 077
USD
|
|
2021-10-05 |
2021-10-04 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
3 029
-9.8%
125,17
379 140
USD
|
3 029
-9.8%
|
125,17
|
379 140
USD
|
|
2021-10-05 |
2021-10-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
8 774
-22.1%
125,18
1 098 329
USD
|
8 774
-22.1%
|
125,18
|
1 098 329
USD
|
|
2021-10-05 |
2021-10-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
1 787
-4.3%
124,17
221 892
USD
|
1 787
-4.3%
|
124,17
|
221 892
USD
|
|
2021-10-05 |
2021-10-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
1 210
-2.8%
123,09
148 939
USD
|
1 210
-2.8%
|
123,09
|
148 939
USD
|
|
2021-10-05 |
2021-10-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
400
-0.9%
121,34
48 536
USD
|
400
-0.9%
|
121,34
|
48 536
USD
|
|
2021-10-05 |
2021-10-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
600
-1.4%
120,13
72 078
USD
|
600
-1.4%
|
120,13
|
72 078
USD
|
|
2021-10-05 |
2021-10-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
700
-1.6%
118,55
82 985
USD
|
700
-1.6%
|
118,55
|
82 985
USD
|
|
2021-10-01 |
2021-10-01 |
VP
Vente planifiée
|
Pande Atul
Administrateur non-exécutif
|
2 500
-100.0%
120,72
301 800
USD
|
2 500
-100.0%
|
120,72
|
301 800
USD
|
|
2021-09-03 |
2021-09-02 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
2 673
-5.7%
125,51
335 488
USD
|
2 673
-5.7%
|
125,51
|
335 488
USD
|
|
2021-09-03 |
2021-09-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
500
-1.1%
119,52
59 760
USD
|
500
-1.1%
|
119,52
|
59 760
USD
|
|
2021-09-03 |
2021-09-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
3 410
-6.7%
118,62
404 494
USD
|
3 410
-6.7%
|
118,62
|
404 494
USD
|
|
2021-09-03 |
2021-09-01 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
1 590
-3.0%
117,87
187 413
USD
|
1 590
-3.0%
|
117,87
|
187 413
USD
|
|
2021-09-01 |
2021-09-01 |
VP
Vente planifiée
|
Pande Atul
Administrateur non-exécutif
|
2 500
-100.0%
117,82
294 550
USD
|
2 500
-100.0%
|
117,82
|
294 550
USD
|
|
2021-06-14 |
2021-06-14 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
8 334
-15.5%
131,44
1 095 421
USD
|
8 334
-15.5%
|
131,44
|
1 095 421
USD
|
|
2021-06-14 |
2021-06-11 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
8 333
-15.5%
129,33
1 077 707
USD
|
8 333
-15.5%
|
129,33
|
1 077 707
USD
|
|
2021-06-14 |
2021-06-10 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
13 333
-22.7%
123,68
1 649 025
USD
|
13 333
-22.7%
|
123,68
|
1 649 025
USD
|
|
2021-06-07 |
2021-06-07 |
V
Vente
|
OLSON LAURIE J
Administrateur non-exécutif
|
4 000
-100.0%
112,93
451 720
USD
|
4 000
-100.0%
|
112,93
|
451 720
USD
|
|
2021-06-01 |
2021-06-01 |
VP
Vente planifiée
|
Pande Atul
Administrateur non-exécutif
|
2 500
-100.0%
111,44
278 600
USD
|
2 500
-100.0%
|
111,44
|
278 600
USD
|
|
2021-05-12 |
2021-05-10 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
5 000
-9.9%
110,43
552 150
USD
|
5 000
-9.9%
|
110,43
|
552 150
USD
|
|
2021-04-14 |
2021-04-12 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
5 000
-9.9%
114,22
571 100
USD
|
5 000
-9.9%
|
114,22
|
571 100
USD
|
|
2021-03-12 |
2021-03-10 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
5 000
-9.9%
118,48
592 400
USD
|
5 000
-9.9%
|
118,48
|
592 400
USD
|
|
2021-03-03 |
2021-03-01 |
VP
Vente planifiée
|
Pande Atul
Administrateur non-exécutif
|
2 500
-100.0%
125,43
313 575
USD
|
2 500
-100.0%
|
125,43
|
313 575
USD
|
|
2021-02-17 |
2021-02-16 |
VP
Vente planifiée
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
10 000
-43.5%
119,57
1 195 700
USD
|
10 000
-43.5%
|
119,57
|
1 195 700
USD
|
|
2021-02-12 |
2021-02-10 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
5 000
-9.9%
114,06
570 300
USD
|
5 000
-9.9%
|
114,06
|
570 300
USD
|
|
2021-02-10 |
2021-02-09 |
V
Vente
|
PureTech Health LLC
Former 10% Owner
|
1 000 000
-29.4%
118,00
118 000 000
USD
|
1 000 000
-29.4%
|
118,00
|
118 000 000
USD
|
|
2021-02-01 |
2021-02-01 |
VP
Vente planifiée
|
Pande Atul
Administrateur non-exécutif
|
2 500
-100.0%
100,00
250 000
USD
|
2 500
-100.0%
|
100,00
|
250 000
USD
|
|
2021-01-12 |
2021-01-11 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
1 428
-3.0%
105,11
150 097
USD
|
1 428
-3.0%
|
105,11
|
150 097
USD
|
|
2021-01-12 |
2021-01-11 |
VP
Vente planifiée
|
Miller Andrew Craig
Chief Operating Officer
Dirigeant
|
3 572
-7.3%
105,11
375 453
USD
|
3 572
-7.3%
|
105,11
|
375 453
USD
|
|
2021-01-12 |
2021-01-08 |
VP
Vente planifiée
|
Ignelzi Troy A.
Chief Financial Officer
Dirigeant
|
8 000
-38.1%
104,49
835 920
USD
|
8 000
-38.1%
|
104,49
|
835 920
USD
|
|
2020-12-14 |
2020-12-14 |
VP
Vente planifiée
|
Pande Atul
Administrateur non-exécutif
|
5 714
-100.0%
92,64
529 345
USD
|
5 714
-100.0%
|
92,64
|
529 345
USD
|
|